Does progesterone improve outcome in diffuse axonal injury?

Soltani, Zahra; Shahrokhi, Nader; Karamouzian, Saeed; Khaksari, Mohammad; Mofid, Behshad; Nakhaee, Nouzar; Reihani, Hamed

Soltani, Zahra; Shahrokhi, Nader; Karamouzian, Saeed; Khaksari, Mohammad; Mofid, Behshad; Nakhaee, Nouzar; Reihani, Hamed.

Afiliación

Soltani Z; a Physiology Research Center, Institute of Neuropharmacology , Afzalipour School of Medical, Kerman University of Medical Sciences , Kerman , Iran.
Shahrokhi N; b Neuroscience Research Center , Institute of Neuropharmacology.
Karamouzian S; c Department of Neurosurgery.
Khaksari M; d Endocrinology and Metabolism Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences , Kerman , Iran.
Mofid B; c Department of Neurosurgery.
Nakhaee N; b Neuroscience Research Center , Institute of Neuropharmacology.
Reihani H; c Department of Neurosurgery.

Brain Inj ; 31(1): 16-23, 2017.

Article en En | MEDLINE | ID: mdl-27819489

Asunto(s)

Lesión Axonal Difusa/tratamiento farmacológico; Fármacos Neuroprotectores/uso terapéutico; Progesterona/uso terapéutico; Adulto; Lesión Axonal Difusa/mortalidad; Escala de Consecuencias de Glasgow; Humanos; Masculino; Método Simple Ciego; Tasa de Supervivencia; Resultado del Tratamiento

Palabras clave

Diffuse axonal injury; Glasgow coma scale; mortality; progesterone

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Progesterona / Fármacos Neuroprotectores / Lesión Axonal Difusa Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Humans / Male Idioma: En Revista: Brain Inj Asunto de la revista: CEREBRO Año: 2017 Tipo del documento: Article País de afiliación: Irán Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google